Cart
sales@molnova.com
Home - Products - NF-κB - Free radical scavengers - Edaravone

Edaravone

CAS No. 89-25-8

Edaravone( Edaravone | NSC 2629 )

Catalog No. M16437 CAS No. 89-25-8

Edaravone(MCI-186), a strong novel free radical scavenger.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 39 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Edaravone
  • Note
    Research use only, not for human use.
  • Brief Description
    Edaravone(MCI-186), a strong novel free radical scavenger.
  • Description
    Edaravone(MCI-186), a strong novel free radical scavenger, is used for treatment of patients with acute brain infarction. (In Vitro):Edaravone performs both preventative and therapeutic effects against toxicity of glutamate. Pretreatment of edaravone reduces the toxicity of glutamate towards SGNs. Edaravone reduces apoptosis and necrosis caused by glutamate. Pretreatment of edaravone (500 μM) reverses these changes to approximately normal levels. The protective effect of edaravone on SGNs against glutamate-induced apoptosis is associated with PI3K/Akt pathway and Bcl-2 protein family.(In Vivo):Edaravone exerts neuroprotective effects by inhibiting endothelial injury and by ameliorating neuronal damage in brain ischemia. Edaravone provides the desirable features of NOS: it increases eNOS (beneficial NOS for rescuing ischemic stroke) and decreases nNOS and iNOS (detrimental NOS). Post-reperfusion brain edema and hemorrhagic events induced by thrombolytic therapy may be reduced by edaravone pretreatment. Edaravone significantly decreases infarct volume, with the average infarct volume in the edaravone-treated rats (227.6 mm3) being significantly lower than that in the control rats (264.0 mm3). Edaravone treatment also decreases the postischemic hemorrhage volumes (53.4 mm3 in edaravone-treated rats vs 176.4 mm3 in controls). In addition, the ratio of hemorrhage volume to infarct volume is lower in the edaravone-treated rats (23.5%) than in the untreated rats (63.2%). In edaravone (20 mg/kg)-treated rats, astrocyte activity (glial fibrillary acidic protein) and apoptotic cells (caspase-3) are decreased on the corpus callosum, germinal matrix, and cerebral cortex.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Edaravone | NSC 2629
  • Pathway
    NF-κB
  • Target
    Free radical scavengers
  • Recptor
    Free radical scavengers
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    89-25-8
  • Formula Weight
    174.2
  • Molecular Formula
    C10H10N2O
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 35 mg/mL (200.91 mM); DMSO: 35 mg/mL (200.91 mM)
  • SMILES
    O=C1CC(C)=NN1C2=CC=CC=C2
  • Chemical Name
    5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yoshida H, et al. CNS Drug Rev, 2006, 12(1), 9-20.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Cycloolivil

    Cycloolivil is a natural polyphenolic compound with a significant radical scavenging activity present in olive trees. Cycloolivil has antioxidant activity, it may prevent thrombotic complications associated to platelet hyperaggregability and be the base.

  • Maclurin

    Maclurin is a phenolic component of mulberry twigs, exerts anti-metastatic effects. Maclurin effectively protects against OH-induced damages to DNA and MSCs and can be used in studies about the prevention of many diseases or MSCs transplantation.

  • Rebamipide

    Rebamipide, an amino acid derivative of 2-(1H)-quinolinone, is used for mucosal protection, healing of gastroduodenal ulcers, and treatment of gastritis.

Sign In Join Free